Brian Armstrong’s NewLimit raises a $130M Series B, laying out road map for anti-aging drugs
Summary
NewLim\xadit, an an\xadti-ag\xading biotech start\xadup backed by Coin\xadbase CEO Bri\xadan Arm\xadstrong, has raised a $130 mil\xadlion Se\xadries B round to get its lead drug can\xaddi\xaddates Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected